Home page

CARDIOPROGRESS
Foundation for the advancement of cardiology

Knowledge, observation, action

  РУС

Feedback

RU EN
  •  About Foundation 
  •  Scientific news 
  •   Events  
  •   Projects  
  •   Guidelines  
  •   Trials  
  •   Editorial activity  
  •   Archive  
  • Главная
  • Сlinical trials

Сlinical trials

 


Prospective Study on Circulating MicroRNAs and Risk of Myocardial Infarction



CARDia: Coronary Artery Revascularisation in Diabetes trial



REVERSE study: CRT produces long-term improvements in disease progression in mildly symptomatic heart failure patients. Five-year results from the REsynchronization reVErses Remodeling in Sys



PRoFESS: Impact of resting heart rates on recurrent stroke, cardiovascular outcomes, disability and cognitive decline in 20.165 patients after ischemic stroke



IABP-SHOCK II: Randomized comparison of intraaortic balloon counterpulsation versus optimal medical therapy in addition to early revascularization in acute myocardial infarction complicated b



DeFACTO: Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography



The Great East Japan Earthquake Disaster and Cardiovascular Diseases



AFib Ablation Pilot: ESC-EURObservational Research Programme: 1-year follow-up of the Atrial Fibrillation Ablation Conducted by the European Heart Rhythm Association



PRAGUE-12: Randomized open multicenter study comparing cardiac surgery with MAZE versus cardiac surgery without MAZE in patients with coronary and/or valvular heart disease and with atrial fi



FAST-MI programme: Decrease in early mortality in STEMI is related to changing patient profile and behavior, as well as improved organization of care: Data from 4 French nationwide surveys ov


Scientific news

  • Ventricular Changes Seem Worse in Persistent vs Paroxysmal AF The study covered in this summary was published on ResearchSquare.org as a preprint and has not yet been peer reviewed.

  • No Thrombotic Risk From Higher Lp(a) Levels Contrary to indications from previous studies, there is no association between increased lipoprotein(a) concentrations and the risk for subsequent thrombotic events, suggests a new large-scale analysis. (Milan)

  • Noninvasive Approach to Revascularization Decisions Shows Promise When deciding on the optimal revascularization strategy for patients with multivessel coronary disease, a noninvasive approach using quantitative flow ratio (QFR) showed substantial agreement with the more invasive classical fractional flow reserve (FFR) approach in a new study.

  • SAFE-PAD Shows Long-Term Safety of Paclitaxel Devices Patients who have paclitaxel-coated stents and balloons have survival and outcomes comparable to those who have a bare-metal stent or percutaneous transluminal angioplasty, according to updated results from a large study of almost 170,000 Medicare beneficiaries.

  • ADT for Prostate Cancer: What's the Risk on the Heart? Androgen deprivation therapy (ADT) for localized prostate cancer increases the risk of myocardial infarction (MI), stroke, and other cardiovascular disease (CVD) events as well as death, according to a study from Norway.

Partners

  • The Department of Health in Moscow
  • The State Committee on Health
  • Silicea-Poligraf, publishing house

Video resource

Channel "Cardioprogress"

Follow us

Top.Mail.Ru

© 2012-2018 Foundation for the advancement of cardiology «Cardioprogress»